Money Is Moving

Public market insider buying at PharmaCielo (V:PCLO)

Updated Wednesday Sep 08, 2021 02:30 AM EDT

Marc Lustig, a Director, acquired 1,617,652 Common Shares on a direct ownership basis at a price of $1.100 on September 3rd, 2021. This represents a $1,779,417 investment into the company's shares and an account share holdings change of greater than 100%.

PharmaCielo is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

Pharmacielo Ltd, formerly AAJ Capital 1 Corp, is a Canada-based company that is engaged in the alternative medicine sector. The Company produces cannabis oils. It offers medicinal-grade oil extracts and related products, which provide relief and wellness formulas for patients in need, including those requiring higher levels of tetrahydrocannabinol (THC). The Company's wholly-owned subsidiary is PharmaCielo Colombia Holdings SAS based in Colombia. The Company works together with Cooperativa Caucannabis and more than 60 local regional farmer members in Cauca, Colombia to cultivate cannabis for the production of standardized, medicinal-grade oil extracts and related products. Pharmacielo Ltd holds Colombian licenses for cannabis.

INK Edge Outlook

CONDITIONS:

6 months ago

1 year ago

Overall

N/A

Rain

Rain

The INK Edge Outlook is a quantitative process that ranks a stock based on our V.I.P. criteria.
View outlooks on all Canadian listed stocks at inkresearch.com.

Go to PharmaCielo Ltd. (PCLO)'s company page

Comment On!

Comment

Image

140

Upload limit is up to 1mb only

Comment On!

No Comments

Twitter

Search (past week) for $PCLO.CA

No tweets found

View on Twitter

Stocktwits

PharmaCielo Ltd.

Symbol not found.

Disclaimer :: Use of this site is subject to, and your continued use constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information. INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion; however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment. Users should always consult with and obtain advice from their professional licensed financial advisor, including their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment or trading securities do so with caution. Users should perform full due diligence and investigate any security fully before making an investment or before the execution of a security trade based upon information learned through INK. Investors should obtain annual reports and other company information to complete their own due diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this website. On this site, there may be third party content, content from authors or links to third-party sites or pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI® is a registered trade-mark owned by the Alberta Securities Commission.Read less

Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.

Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.